Some studies suggest that cystic fibrosis or CBAVD males carrying CFTR mutations may experience poorer ICSI treatment outcomes [11–13], while other research finds no significant difference in ICSI treatment results between CBAVD patients with or without CFTR gene mutations [14, 15]. The gene discussed is CFTR; the disease is cystic fibrosis.